Xenon Pharmaceuticals - Common Shares (XENE)'s 30-day implied volatility (IV30) was 39.7% at the close on November 6, 2026, down from 57.4% the day before, against a 52-week range of 25.6% to 180.6%. Its 20-day historical volatility was 37.9%.
Data as of November 6, 2026.